If you’ve started semaglutide or tirzepatide and noticed things have slowed down — literally — you’re not imagining it. GLP-1 constipation is one of the most commonly reported gastrointestinal side effects of these medications, and it catches a lot of patients off guard because it isn’t always covered in the initial conversation about nausea and appetite changes. The good news is that it’s usually manageable with a few targeted adjustments, and understanding why it happens makes it much easier to get ahead of it.
What Is GLP-1 Constipation and Why Does It Happen?
Semaglutide and tirzepatide belong to a class of medications that work, in part, by slowing gastric emptying — the rate at which food moves out of your stomach and through your digestive tract. This delay is a key part of why these medications help you feel full longer, but the same mechanism that curbs appetite also slows the transit of food through your intestines, which can lead to harder stools and less frequent bowel movements. Tirzepatide adds a second mechanism on top of this, acting on both GLP-1 and GIP receptors, which some research suggests may amplify gastrointestinal effects for some patients compared with GLP-1-only medications.
On top of the direct pharmacological effect, three other common patterns during treatment tend to make constipation worse:
- Eating significantly less food overall, which means less bulk moving through the colon
- Reduced fluid intake, often because appetite and thirst cues both drop
- Lower fiber intake if meals shift toward smaller portions of familiar “safe” foods rather than balanced, high-fiber choices
If you’ve read our guide on tirzepatide side effects or semaglutide side effects, you already know constipation sits alongside nausea and early fullness as one of the most frequently reported effects of GLP-1 therapy. This post goes deeper into that one symptom specifically, since it tends to linger longer than nausea for many patients and responds well to specific, practical changes.
How Common Is Constipation on Semaglutide and Tirzepatide?
Gastrointestinal side effects, including constipation, were among the most frequently reported adverse events in the pivotal trials for both medications. In the STEP 1 trial (Wilding et al., NEJM 2021), gastrointestinal events — including constipation — were more common in the semaglutide group than in the placebo group, though the majority were mild to moderate and transient. Similarly, in the SURMOUNT-1 trial (Jastreboff et al., NEJM 2022), gastrointestinal adverse events, including constipation, were reported across all tirzepatide dose groups, generally during the dose-escalation phase.
Constipation on GLP-1 medications is usually mild and improves with the strategies below, but it isn’t always trivial. Case reports in the medical literature have documented rare but serious complications — including bowel obstruction and complicated diverticulitis — in patients on these medications, which is a reminder that persistent or worsening symptoms deserve a conversation with your provider rather than being pushed through on your own.
Diet Changes That Help With GLP-1 Constipation
Because appetite suppression naturally shrinks portion sizes, it’s easy to end up eating far less fiber than before treatment without realizing it. A few practical shifts make a meaningful difference:
- Prioritize fiber-dense foods within smaller portions — vegetables, berries, chia seeds, ground flaxseed, and legumes pack more fiber per bite than refined carbohydrates, which matters when your total food volume is lower
- Introduce fiber gradually — a sudden jump in fiber without adequate fluid can worsen bloating and discomfort, so build up over one to two weeks
- Don’t skip meals entirely — regular, smaller meals help maintain digestive motility better than long gaps followed by one larger meal
Our 7-day GLP-1 meal plan is built with this in mind, balancing protein needs with fiber-forward choices that work within a lower overall appetite. It’s also worth reviewing our list of foods to avoid while taking tirzepatide, since some of the foods that worsen nausea and reflux on GLP-1 medications — heavy, fatty, or highly processed options — also tend to be lower in the fiber that helps keep things moving.
Hydration’s Role in Preventing GLP-1 Constipation
Fiber alone doesn’t solve constipation — without enough fluid, added fiber can actually make stools harder rather than softer. This is one of the most overlooked pieces of managing GLP-1 constipation, particularly because thirst cues often become less reliable alongside appetite changes on these medications.
We cover this in detail in our guide to hydration on tirzepatide and semaglutide, but the short version is: consistent water intake throughout the day matters more than trying to catch up with a large volume all at once. Some patients find it helpful to set reminders or pair water intake with existing habits (a glass with each meal, one before each dose) since GLP-1 medications can blunt the natural thirst signal that would otherwise prompt you to drink.
Movement and Activity
Physical activity stimulates intestinal motility — it’s one of the more consistent, low-risk interventions for constipation across many causes, not just GLP-1 medications. Even a daily 15–20 minute walk can help, and this doesn’t need to be a formal exercise program to have an effect. If you’re also working on preserving muscle mass during treatment, combining short daily walks with light resistance activity supports both digestive regularity and the lean mass goals we discuss in our post on protein and muscle preservation on semaglutide.
Over-the-Counter and Lifestyle Approaches
For constipation that doesn’t resolve with diet, hydration, and movement alone, several over-the-counter categories are commonly used and can be discussed with your provider:
- Fiber supplements (such as psyllium husk) to add bulk when dietary fiber alone isn’t enough
- Osmotic laxatives (such as polyethylene glycol), which draw water into the colon to soften stool
- Stool softeners for milder cases where straining is the main issue
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has helpful general guidance on how these categories work and how they differ. Because everyone’s digestive history and medication list are different, it’s worth confirming any new supplement or over-the-counter product with your prescribing provider rather than self-selecting based on what worked for someone else — this is exactly the kind of question a consultation is designed for.
When GLP-1 Constipation Signals a Bigger Problem
Most constipation on semaglutide or tirzepatide is uncomfortable but not dangerous, and tends to ease as your body adjusts to a given dose. That said, certain symptoms warrant prompt medical attention rather than home management:
- No bowel movement for several days combined with abdominal pain, bloating, or vomiting
- Severe or worsening abdominal pain, especially if it’s localized rather than generalized
- Inability to pass gas along with abdominal distension
- Fever alongside digestive symptoms
These can be signs of more serious complications, including bowel obstruction, which — while uncommon — has been documented in case reports involving GLP-1 medications, particularly in patients with pre-existing digestive conditions such as diverticular disease. This is one of several reasons ongoing medical supervision matters throughout treatment, not just at the start.
Talking to Your Provider About GLP-1 Constipation
Constipation that persists despite diet, hydration, and activity changes is a normal, common reason to check in with your care team — it doesn’t necessarily mean you need to stop treatment. Depending on how you’re responding overall, your provider might recommend a slower dose titration, additional supportive strategies, or simply more time to adjust. If you haven’t started treatment yet and want to talk through what to expect, our consultation process walks through what a typical visit and follow-up schedule looks like.
Frequently Asked Questions
Does tirzepatide cause more constipation than semaglutide?
Both medications list constipation as a common gastrointestinal side effect in their respective clinical trial programs. Individual response varies significantly, and neither medication can be said to universally cause more constipation than the other for a given patient.
How long does GLP-1 constipation typically last?
For many patients, gastrointestinal side effects — including constipation — are most noticeable during dose increases and tend to ease as the body adjusts to a stable dose. Ongoing or worsening symptoms should be discussed with your provider rather than assumed to be temporary.
Can I take a laxative while on semaglutide or tirzepatide?
Many patients use over-the-counter fiber supplements or laxatives alongside GLP-1 medications, but it’s best to confirm the specific product and any interactions with your prescribing provider first.
Is constipation a sign my dose is too high?
Not necessarily — constipation can occur at any dose, though gastrointestinal symptoms in general are often most pronounced during the escalation phase. If it’s significantly affecting your quality of life, that’s worth raising with your provider, who can weigh whether a different titration pace makes sense for you.
Medica Weight Loss offers compounded semaglutide and tirzepatide, prepared by a state-licensed compounding pharmacy based on a valid individual prescription. These compounded medications are not FDA-approved — they have not been evaluated by the FDA for safety, effectiveness, or quality. Any reference to FDA-approved medications elsewhere refers solely to brand-name formulations such as Wegovy®, Ozempic®, Zepbound®, and Mounjaro®, which are not what Medica Weight Loss dispenses.
